In the News

Share
1669 News Items found
Craig Melvin
Why Colorectal Cancer Screening Is Crucial for Younger Adults and Black People
NBC News anchor Craig Melvin led MSK experts in a discussion about racial and age trends in colorectal cancer and when people should start screening for the disease.
A doctor showing a textured and smooth implant to their patient
Breast Implants and Cancer: What Patients Need to Know
Learn what you need to know about safety requirements for breast implants.
Feature
A healthcare provider comforts a patient by resting their hands on a patient's arm.
Cord Blood Transplants for Leukemia, Lymphoma, and Myeloma Save Lives at MSK
Nearly 400 adults and children have received umbilical cord blood transplants at MSK. These transplants offer the best chance of a cure for blood cancer in patients who are unable to find a matched donor, often due to their non-European ancestry.
Education
Steven Wang with a patient
Accessing Your Medical Information: The Latest on What You Need to Know about the 21st Century Cures Act
Learn about the 21st Century Cures Act, which set out to improve the way providers share information to coordinate the care of their patients and to improve patients’ access to their own medical information.
Q&A
genitourinary medical oncologist Robert Motzer
Immunotherapy for Kidney Cancer: Learn About the Latest Advances
Immunotherapy drugs called checkpoint inhibitors are effective against many cancers, including kidney cancer. Learn how these drugs are used to treat both early- and late-stage disease.
Mini Kamboj, MSK's Chief Medical Epidemiologist
Polio in NY: What You Should Know
Learn what detection of the polio virus in New York State means for you.
MSK medical oncologist Jonathan Rosenberg, who treats bladder cancer.
Powerful New Bladder Cancer Treatments: Antibody-Drug Conjugates and Checkpoint Inhibitors
Antibody-drug conjugates and checkpoint inhibitors show promise as new therapies for bladder cancer.
Paige Arnold working in a lab
2022 GSK Chairman’s Prize Celebrates Research That Sheds Light on Cellular Metabolic Processes
Paige Arnold, who will graduate from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) next spring, has been awarded the 2022 Chairman’s Prize. The competitive award is presented annually and was established by GSK’s Board of Trustees Chair Emeritus Louis V. Gerstner, Jr., for whom the school is named.
Q&A
Sandra Brennan with a patient
Dense Breast Tissue & Cancer Risk: What You Should Know
In this Q&A, MSK radiologist Sandra Brennan discusses what is known about the link between breast density and cancer risk.
MSK Kids patient Rihanna Plaza
Thanks to MSK's Expertise in Pediatric Cancer Genomics, Rihanna Goes to Kindergarten
Prognosis for Rihanna’s cancer with an NTRK gene mutation improved with larotrectinib, a targeted therapy.
MSK physician-scientist Charles Sawyers and SKI computational biologist Dana Pe’er
MSK Researchers Discover How Cancer Cells Change Identity To Escape Therapies
Researchers learn how prostate cancer cells change their type to survive treatment.
Feature
A bowl of ginseng root sitting next to a teapot.
Natural Remedies for Dry Mouth (Xerostomia)
Discover some natural remedies for mouth dryness (xerostomia) and mouth sores, common side effects of cancer treatment.
Finding
Two chimpanzees in a field
Cancer Genes in Humans vs. Chimps: Why Are We More Susceptible?
In an unusual collaboration, scientists from MSK and the American Museum of Natural History looked at how the BRCA2 gene differs between humans and chimps. Mutations in this gene are linked to an increased risk of certain cancers, including breast cancer.
Q&A
physiatrist Jesuel Padro-Guzman
Answers to 8 FAQ About Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Peripheral neuropathy is a common side effect of many types of chemotherapy. Learn about what it is, why it happens, and how to treat CIPN.
In the Lab
Scott Lowe
SKI Scientists Solve 30-Year-Old Mystery About p53 Protein — Dubbed ‘Guardian of the Genome’
Rather than promoting genetic chaos, loss of p53 leads to an orderly progression of genetic changes that no one saw coming.
Dr. Bob Li
First Drug Targeting HER2-Mutant Non-Small Cell Lung Cancer Approved by FDA
The FDA has approved the drug trastuzumab deruxtecan for the treatment of advanced non-small cell lung cancer driven by mutant HER2. An MSK-led study published in September 2021 contributed to the drug's approval.
pancreatic surgeon and K12 alum Vinod Balachandran
MSK Program Prepares Clinicians for Careers in Translational Cancer Research
In the past 30 years, major strides have been made in translational medicine — the bridge that shepherds research findings from the lab to clinical practice. Researchers, physicians, and other specialists at Memorial Sloan Kettering Cancer Center (MSK) have played a major role in these successes, as they work together with the common goal of using their discoveries to create new treatments for people with cancer.
In the Clinic
Shanu Modi
FDA Approves First Targeted Drug To Treat HER2-Low Breast Cancer: Trastuzumab Deruxtecan (T-DXd)
On August 5, 2022, the FDA approved the first targeted therapy for patients with HER2-low breast cancer that has spread to other parts of the body and is unable to be surgically removed. The drug, trastuzumab deruxtecan (T-DXd), was approved based on a clinical trial led by Memorial Sloan Kettering Cancer Center (MSK) breast medical oncologist Shanu Modi.
Q&A
MSK medical oncologist Smita Joshi, who specializes in esophageal cancer.
Esophageal Cancer Risk: The Truth About Hot Drinks Like Coffee and Tea
There is very little evidence that drinking hot beverages increases esophageal cancer risk.
Man putting on sunscreen
Can Tattoos Hide Skin Cancer? Advice From MSK on How To Stay Safe
First, the good news: There’s no evidence that tattoos cause skin cancer, says Memorial Sloan Kettering Cancer Center (MSK) dermatologist Jennifer DeFa...